nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP2C9—Ifosfamide—testicular cancer	0.118	0.352	CbGbCtD
Glipizide—CYP3A4—Ifosfamide—testicular cancer	0.0684	0.204	CbGbCtD
Glipizide—CYP2C9—Cisplatin—testicular cancer	0.0573	0.171	CbGbCtD
Glipizide—CYP3A4—Vinblastine—testicular cancer	0.0363	0.108	CbGbCtD
Glipizide—CYP3A4—Etoposide—testicular cancer	0.0327	0.0977	CbGbCtD
Glipizide—CYP3A4—Doxorubicin—testicular cancer	0.0223	0.0667	CbGbCtD
Glipizide—PPARG—Teniposide—Etoposide—testicular cancer	0.0163	1	CbGdCrCtD
Glipizide—Hyperhidrosis—Cisplatin—testicular cancer	0.00122	0.00188	CcSEcCtD
Glipizide—Pruritus—Bleomycin—testicular cancer	0.00121	0.00187	CcSEcCtD
Glipizide—Feeling abnormal—Ifosfamide—testicular cancer	0.00121	0.00186	CcSEcCtD
Glipizide—Nausea—Vinblastine—testicular cancer	0.0012	0.00186	CcSEcCtD
Glipizide—Abdominal pain upper—Epirubicin—testicular cancer	0.0012	0.00186	CcSEcCtD
Glipizide—Anorexia—Cisplatin—testicular cancer	0.0012	0.00185	CcSEcCtD
Glipizide—Migraine—Doxorubicin—testicular cancer	0.0012	0.00185	CcSEcCtD
Glipizide—Gastrointestinal pain—Ifosfamide—testicular cancer	0.0012	0.00184	CcSEcCtD
Glipizide—Discomfort—Etoposide—testicular cancer	0.00119	0.00184	CcSEcCtD
Glipizide—Hypersensitivity—Dactinomycin—testicular cancer	0.00118	0.00181	CcSEcCtD
Glipizide—Abdominal discomfort—Methotrexate—testicular cancer	0.00117	0.0018	CcSEcCtD
Glipizide—Confusional state—Etoposide—testicular cancer	0.00117	0.0018	CcSEcCtD
Glipizide—Urticaria—Ifosfamide—testicular cancer	0.00116	0.00179	CcSEcCtD
Glipizide—Abdominal pain—Ifosfamide—testicular cancer	0.00116	0.00178	CcSEcCtD
Glipizide—Pancytopenia—Methotrexate—testicular cancer	0.00116	0.00178	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00115	0.00177	CcSEcCtD
Glipizide—Asthenia—Dactinomycin—testicular cancer	0.00115	0.00177	CcSEcCtD
Glipizide—Dysuria—Methotrexate—testicular cancer	0.00114	0.00175	CcSEcCtD
Glipizide—Paraesthesia—Cisplatin—testicular cancer	0.00113	0.00175	CcSEcCtD
Glipizide—Thrombocytopenia—Etoposide—testicular cancer	0.00113	0.00174	CcSEcCtD
Glipizide—Dyspnoea—Cisplatin—testicular cancer	0.00113	0.00173	CcSEcCtD
Glipizide—Hyperhidrosis—Etoposide—testicular cancer	0.00112	0.00172	CcSEcCtD
Glipizide—Abdominal pain upper—Doxorubicin—testicular cancer	0.00111	0.00172	CcSEcCtD
Glipizide—Photosensitivity reaction—Methotrexate—testicular cancer	0.00111	0.00171	CcSEcCtD
Glipizide—Anorexia—Etoposide—testicular cancer	0.0011	0.0017	CcSEcCtD
Glipizide—Decreased appetite—Cisplatin—testicular cancer	0.0011	0.00169	CcSEcCtD
Glipizide—Diarrhoea—Dactinomycin—testicular cancer	0.00109	0.00168	CcSEcCtD
Glipizide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00109	0.00168	CcSEcCtD
Glipizide—Vomiting—Bleomycin—testicular cancer	0.00109	0.00168	CcSEcCtD
Glipizide—Drowsiness—Methotrexate—testicular cancer	0.00109	0.00167	CcSEcCtD
Glipizide—Pancytopenia—Epirubicin—testicular cancer	0.00108	0.00167	CcSEcCtD
Glipizide—Rash—Bleomycin—testicular cancer	0.00108	0.00166	CcSEcCtD
Glipizide—Pain—Cisplatin—testicular cancer	0.00108	0.00166	CcSEcCtD
Glipizide—Dermatitis—Bleomycin—testicular cancer	0.00108	0.00166	CcSEcCtD
Glipizide—Hypersensitivity—Ifosfamide—testicular cancer	0.00108	0.00166	CcSEcCtD
Glipizide—Dysuria—Epirubicin—testicular cancer	0.00107	0.00164	CcSEcCtD
Glipizide—Conjunctivitis—Methotrexate—testicular cancer	0.00106	0.00163	CcSEcCtD
Glipizide—Asthenia—Ifosfamide—testicular cancer	0.00105	0.00162	CcSEcCtD
Glipizide—Sweating—Methotrexate—testicular cancer	0.00104	0.0016	CcSEcCtD
Glipizide—Photosensitivity reaction—Epirubicin—testicular cancer	0.00104	0.0016	CcSEcCtD
Glipizide—Feeling abnormal—Cisplatin—testicular cancer	0.00104	0.0016	CcSEcCtD
Glipizide—Paraesthesia—Etoposide—testicular cancer	0.00104	0.0016	CcSEcCtD
Glipizide—Pruritus—Ifosfamide—testicular cancer	0.00104	0.0016	CcSEcCtD
Glipizide—Dyspnoea—Etoposide—testicular cancer	0.00103	0.00159	CcSEcCtD
Glipizide—Somnolence—Etoposide—testicular cancer	0.00103	0.00158	CcSEcCtD
Glipizide—Hepatobiliary disease—Methotrexate—testicular cancer	0.00103	0.00158	CcSEcCtD
Glipizide—Nausea—Bleomycin—testicular cancer	0.00102	0.00157	CcSEcCtD
Glipizide—Drowsiness—Epirubicin—testicular cancer	0.00102	0.00157	CcSEcCtD
Glipizide—Vomiting—Dactinomycin—testicular cancer	0.00102	0.00157	CcSEcCtD
Glipizide—Agranulocytosis—Methotrexate—testicular cancer	0.00101	0.00156	CcSEcCtD
Glipizide—Rash—Dactinomycin—testicular cancer	0.00101	0.00155	CcSEcCtD
Glipizide—Decreased appetite—Etoposide—testicular cancer	0.00101	0.00155	CcSEcCtD
Glipizide—Diarrhoea—Ifosfamide—testicular cancer	0.001	0.00154	CcSEcCtD
Glipizide—Pancytopenia—Doxorubicin—testicular cancer	0.001	0.00154	CcSEcCtD
Glipizide—Gastrointestinal disorder—Etoposide—testicular cancer	0.000998	0.00154	CcSEcCtD
Glipizide—Jaundice—Epirubicin—testicular cancer	0.000991	0.00153	CcSEcCtD
Glipizide—Constipation—Etoposide—testicular cancer	0.000989	0.00152	CcSEcCtD
Glipizide—Pain—Etoposide—testicular cancer	0.000989	0.00152	CcSEcCtD
Glipizide—Conjunctivitis—Epirubicin—testicular cancer	0.000988	0.00152	CcSEcCtD
Glipizide—Dysuria—Doxorubicin—testicular cancer	0.000986	0.00152	CcSEcCtD
Glipizide—Hepatitis—Methotrexate—testicular cancer	0.000975	0.0015	CcSEcCtD
Glipizide—Sweating—Epirubicin—testicular cancer	0.000974	0.0015	CcSEcCtD
Glipizide—Dizziness—Ifosfamide—testicular cancer	0.000968	0.00149	CcSEcCtD
Glipizide—Pharyngitis—Methotrexate—testicular cancer	0.000968	0.00149	CcSEcCtD
Glipizide—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000963	0.00148	CcSEcCtD
Glipizide—Hepatobiliary disease—Epirubicin—testicular cancer	0.000961	0.00148	CcSEcCtD
Glipizide—Feeling abnormal—Etoposide—testicular cancer	0.000953	0.00147	CcSEcCtD
Glipizide—Nausea—Dactinomycin—testicular cancer	0.000949	0.00146	CcSEcCtD
Glipizide—Agranulocytosis—Epirubicin—testicular cancer	0.000948	0.00146	CcSEcCtD
Glipizide—Gastrointestinal pain—Etoposide—testicular cancer	0.000946	0.00146	CcSEcCtD
Glipizide—Drowsiness—Doxorubicin—testicular cancer	0.00094	0.00145	CcSEcCtD
Glipizide—Visual impairment—Methotrexate—testicular cancer	0.000939	0.00145	CcSEcCtD
Glipizide—Vomiting—Ifosfamide—testicular cancer	0.000931	0.00143	CcSEcCtD
Glipizide—Hypersensitivity—Cisplatin—testicular cancer	0.00093	0.00143	CcSEcCtD
Glipizide—Rash—Ifosfamide—testicular cancer	0.000923	0.00142	CcSEcCtD
Glipizide—Dermatitis—Ifosfamide—testicular cancer	0.000922	0.00142	CcSEcCtD
Glipizide—Urticaria—Etoposide—testicular cancer	0.000919	0.00142	CcSEcCtD
Glipizide—Jaundice—Doxorubicin—testicular cancer	0.000917	0.00141	CcSEcCtD
Glipizide—Rhinitis—Epirubicin—testicular cancer	0.000915	0.00141	CcSEcCtD
Glipizide—Abdominal pain—Etoposide—testicular cancer	0.000914	0.00141	CcSEcCtD
Glipizide—Conjunctivitis—Doxorubicin—testicular cancer	0.000914	0.00141	CcSEcCtD
Glipizide—Hepatitis—Epirubicin—testicular cancer	0.000912	0.00141	CcSEcCtD
Glipizide—Eye disorder—Methotrexate—testicular cancer	0.000911	0.0014	CcSEcCtD
Glipizide—Hypoaesthesia—Epirubicin—testicular cancer	0.000908	0.0014	CcSEcCtD
Glipizide—Asthenia—Cisplatin—testicular cancer	0.000906	0.0014	CcSEcCtD
Glipizide—Pharyngitis—Epirubicin—testicular cancer	0.000905	0.0014	CcSEcCtD
Glipizide—Sweating—Doxorubicin—testicular cancer	0.000901	0.00139	CcSEcCtD
Glipizide—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000889	0.00137	CcSEcCtD
Glipizide—Visual impairment—Epirubicin—testicular cancer	0.000879	0.00135	CcSEcCtD
Glipizide—Agranulocytosis—Doxorubicin—testicular cancer	0.000878	0.00135	CcSEcCtD
Glipizide—Chills—Methotrexate—testicular cancer	0.000875	0.00135	CcSEcCtD
Glipizide—Nausea—Ifosfamide—testicular cancer	0.00087	0.00134	CcSEcCtD
Glipizide—Diarrhoea—Cisplatin—testicular cancer	0.000864	0.00133	CcSEcCtD
Glipizide—Eye disorder—Epirubicin—testicular cancer	0.000853	0.00131	CcSEcCtD
Glipizide—Hypersensitivity—Etoposide—testicular cancer	0.000852	0.00131	CcSEcCtD
Glipizide—Erythema—Methotrexate—testicular cancer	0.000849	0.00131	CcSEcCtD
Glipizide—Flushing—Epirubicin—testicular cancer	0.000847	0.0013	CcSEcCtD
Glipizide—Rhinitis—Doxorubicin—testicular cancer	0.000846	0.0013	CcSEcCtD
Glipizide—Hepatitis—Doxorubicin—testicular cancer	0.000844	0.0013	CcSEcCtD
Glipizide—Hypoaesthesia—Doxorubicin—testicular cancer	0.00084	0.00129	CcSEcCtD
Glipizide—Pharyngitis—Doxorubicin—testicular cancer	0.000838	0.00129	CcSEcCtD
Glipizide—Asthenia—Etoposide—testicular cancer	0.00083	0.00128	CcSEcCtD
Glipizide—Chills—Epirubicin—testicular cancer	0.000819	0.00126	CcSEcCtD
Glipizide—Pruritus—Etoposide—testicular cancer	0.000818	0.00126	CcSEcCtD
Glipizide—Arrhythmia—Epirubicin—testicular cancer	0.000815	0.00126	CcSEcCtD
Glipizide—Visual impairment—Doxorubicin—testicular cancer	0.000813	0.00125	CcSEcCtD
Glipizide—Vomiting—Cisplatin—testicular cancer	0.000802	0.00124	CcSEcCtD
Glipizide—Vision blurred—Methotrexate—testicular cancer	0.0008	0.00123	CcSEcCtD
Glipizide—Rash—Cisplatin—testicular cancer	0.000796	0.00123	CcSEcCtD
Glipizide—Dermatitis—Cisplatin—testicular cancer	0.000795	0.00122	CcSEcCtD
Glipizide—Erythema—Epirubicin—testicular cancer	0.000794	0.00122	CcSEcCtD
Glipizide—Diarrhoea—Etoposide—testicular cancer	0.000791	0.00122	CcSEcCtD
Glipizide—Eye disorder—Doxorubicin—testicular cancer	0.000789	0.00122	CcSEcCtD
Glipizide—Ill-defined disorder—Methotrexate—testicular cancer	0.000787	0.00121	CcSEcCtD
Glipizide—Flushing—Doxorubicin—testicular cancer	0.000783	0.00121	CcSEcCtD
Glipizide—Flatulence—Epirubicin—testicular cancer	0.000783	0.00121	CcSEcCtD
Glipizide—Tension—Epirubicin—testicular cancer	0.000779	0.0012	CcSEcCtD
Glipizide—Nervousness—Epirubicin—testicular cancer	0.000771	0.00119	CcSEcCtD
Glipizide—Malaise—Methotrexate—testicular cancer	0.000765	0.00118	CcSEcCtD
Glipizide—Dizziness—Etoposide—testicular cancer	0.000765	0.00118	CcSEcCtD
Glipizide—Muscle spasms—Epirubicin—testicular cancer	0.000764	0.00118	CcSEcCtD
Glipizide—Vertigo—Methotrexate—testicular cancer	0.000762	0.00117	CcSEcCtD
Glipizide—Leukopenia—Methotrexate—testicular cancer	0.00076	0.00117	CcSEcCtD
Glipizide—Chills—Doxorubicin—testicular cancer	0.000757	0.00117	CcSEcCtD
Glipizide—Arrhythmia—Doxorubicin—testicular cancer	0.000754	0.00116	CcSEcCtD
Glipizide—Nausea—Cisplatin—testicular cancer	0.00075	0.00116	CcSEcCtD
Glipizide—Vision blurred—Epirubicin—testicular cancer	0.000748	0.00115	CcSEcCtD
Glipizide—Ill-defined disorder—Epirubicin—testicular cancer	0.000737	0.00114	CcSEcCtD
Glipizide—Vomiting—Etoposide—testicular cancer	0.000735	0.00113	CcSEcCtD
Glipizide—Erythema—Doxorubicin—testicular cancer	0.000735	0.00113	CcSEcCtD
Glipizide—Rash—Etoposide—testicular cancer	0.000729	0.00112	CcSEcCtD
Glipizide—Dermatitis—Etoposide—testicular cancer	0.000728	0.00112	CcSEcCtD
Glipizide—Headache—Etoposide—testicular cancer	0.000724	0.00112	CcSEcCtD
Glipizide—Flatulence—Doxorubicin—testicular cancer	0.000724	0.00112	CcSEcCtD
Glipizide—Myalgia—Methotrexate—testicular cancer	0.000722	0.00111	CcSEcCtD
Glipizide—Arthralgia—Methotrexate—testicular cancer	0.000722	0.00111	CcSEcCtD
Glipizide—Tension—Doxorubicin—testicular cancer	0.000721	0.00111	CcSEcCtD
Glipizide—Malaise—Epirubicin—testicular cancer	0.000716	0.0011	CcSEcCtD
Glipizide—Discomfort—Methotrexate—testicular cancer	0.000714	0.0011	CcSEcCtD
Glipizide—Nervousness—Doxorubicin—testicular cancer	0.000714	0.0011	CcSEcCtD
Glipizide—Vertigo—Epirubicin—testicular cancer	0.000714	0.0011	CcSEcCtD
Glipizide—Syncope—Epirubicin—testicular cancer	0.000712	0.0011	CcSEcCtD
Glipizide—Leukopenia—Epirubicin—testicular cancer	0.000711	0.0011	CcSEcCtD
Glipizide—Muscle spasms—Doxorubicin—testicular cancer	0.000706	0.00109	CcSEcCtD
Glipizide—Confusional state—Methotrexate—testicular cancer	0.000698	0.00108	CcSEcCtD
Glipizide—Loss of consciousness—Epirubicin—testicular cancer	0.000698	0.00108	CcSEcCtD
Glipizide—Vision blurred—Doxorubicin—testicular cancer	0.000693	0.00107	CcSEcCtD
Glipizide—Nausea—Etoposide—testicular cancer	0.000687	0.00106	CcSEcCtD
Glipizide—Hypertension—Epirubicin—testicular cancer	0.000686	0.00106	CcSEcCtD
Glipizide—Ill-defined disorder—Doxorubicin—testicular cancer	0.000682	0.00105	CcSEcCtD
Glipizide—Thrombocytopenia—Methotrexate—testicular cancer	0.000678	0.00104	CcSEcCtD
Glipizide—Myalgia—Epirubicin—testicular cancer	0.000676	0.00104	CcSEcCtD
Glipizide—Arthralgia—Epirubicin—testicular cancer	0.000676	0.00104	CcSEcCtD
Glipizide—Anxiety—Epirubicin—testicular cancer	0.000674	0.00104	CcSEcCtD
Glipizide—Hyperhidrosis—Methotrexate—testicular cancer	0.00067	0.00103	CcSEcCtD
Glipizide—Discomfort—Epirubicin—testicular cancer	0.000668	0.00103	CcSEcCtD
Glipizide—Malaise—Doxorubicin—testicular cancer	0.000663	0.00102	CcSEcCtD
Glipizide—Vertigo—Doxorubicin—testicular cancer	0.00066	0.00102	CcSEcCtD
Glipizide—Anorexia—Methotrexate—testicular cancer	0.00066	0.00102	CcSEcCtD
Glipizide—Syncope—Doxorubicin—testicular cancer	0.000659	0.00102	CcSEcCtD
Glipizide—Leukopenia—Doxorubicin—testicular cancer	0.000658	0.00101	CcSEcCtD
Glipizide—Confusional state—Epirubicin—testicular cancer	0.000654	0.00101	CcSEcCtD
Glipizide—Oedema—Epirubicin—testicular cancer	0.000648	0.000999	CcSEcCtD
Glipizide—Loss of consciousness—Doxorubicin—testicular cancer	0.000646	0.000995	CcSEcCtD
Glipizide—Shock—Epirubicin—testicular cancer	0.000638	0.000982	CcSEcCtD
Glipizide—Thrombocytopenia—Epirubicin—testicular cancer	0.000635	0.000978	CcSEcCtD
Glipizide—Hypertension—Doxorubicin—testicular cancer	0.000634	0.000977	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000631	0.000972	CcSEcCtD
Glipizide—Hyperhidrosis—Epirubicin—testicular cancer	0.000627	0.000965	CcSEcCtD
Glipizide—Insomnia—Methotrexate—testicular cancer	0.000626	0.000965	CcSEcCtD
Glipizide—Myalgia—Doxorubicin—testicular cancer	0.000626	0.000964	CcSEcCtD
Glipizide—Arthralgia—Doxorubicin—testicular cancer	0.000626	0.000964	CcSEcCtD
Glipizide—Anxiety—Doxorubicin—testicular cancer	0.000623	0.000961	CcSEcCtD
Glipizide—Paraesthesia—Methotrexate—testicular cancer	0.000622	0.000958	CcSEcCtD
Glipizide—Discomfort—Doxorubicin—testicular cancer	0.000618	0.000952	CcSEcCtD
Glipizide—Anorexia—Epirubicin—testicular cancer	0.000618	0.000952	CcSEcCtD
Glipizide—Dyspnoea—Methotrexate—testicular cancer	0.000617	0.000951	CcSEcCtD
Glipizide—Somnolence—Methotrexate—testicular cancer	0.000616	0.000949	CcSEcCtD
Glipizide—Dyspepsia—Methotrexate—testicular cancer	0.00061	0.000939	CcSEcCtD
Glipizide—Confusional state—Doxorubicin—testicular cancer	0.000605	0.000932	CcSEcCtD
Glipizide—Decreased appetite—Methotrexate—testicular cancer	0.000602	0.000928	CcSEcCtD
Glipizide—Oedema—Doxorubicin—testicular cancer	0.0006	0.000924	CcSEcCtD
Glipizide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000598	0.000921	CcSEcCtD
Glipizide—Pain—Methotrexate—testicular cancer	0.000592	0.000913	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000591	0.00091	CcSEcCtD
Glipizide—Shock—Doxorubicin—testicular cancer	0.00059	0.000909	CcSEcCtD
Glipizide—Thrombocytopenia—Doxorubicin—testicular cancer	0.000587	0.000905	CcSEcCtD
Glipizide—Insomnia—Epirubicin—testicular cancer	0.000586	0.000903	CcSEcCtD
Glipizide—Paraesthesia—Epirubicin—testicular cancer	0.000582	0.000897	CcSEcCtD
Glipizide—Hyperhidrosis—Doxorubicin—testicular cancer	0.00058	0.000893	CcSEcCtD
Glipizide—Dyspnoea—Epirubicin—testicular cancer	0.000578	0.00089	CcSEcCtD
Glipizide—Somnolence—Epirubicin—testicular cancer	0.000576	0.000888	CcSEcCtD
Glipizide—Anorexia—Doxorubicin—testicular cancer	0.000572	0.000881	CcSEcCtD
Glipizide—Feeling abnormal—Methotrexate—testicular cancer	0.000571	0.000879	CcSEcCtD
Glipizide—Dyspepsia—Epirubicin—testicular cancer	0.000571	0.000879	CcSEcCtD
Glipizide—Gastrointestinal pain—Methotrexate—testicular cancer	0.000566	0.000873	CcSEcCtD
Glipizide—Decreased appetite—Epirubicin—testicular cancer	0.000563	0.000868	CcSEcCtD
Glipizide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00056	0.000862	CcSEcCtD
Glipizide—Pain—Epirubicin—testicular cancer	0.000554	0.000854	CcSEcCtD
Glipizide—Constipation—Epirubicin—testicular cancer	0.000554	0.000854	CcSEcCtD
Glipizide—Urticaria—Methotrexate—testicular cancer	0.00055	0.000848	CcSEcCtD
Glipizide—Abdominal pain—Methotrexate—testicular cancer	0.000548	0.000844	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000546	0.000842	CcSEcCtD
Glipizide—Insomnia—Doxorubicin—testicular cancer	0.000542	0.000836	CcSEcCtD
Glipizide—Paraesthesia—Doxorubicin—testicular cancer	0.000539	0.00083	CcSEcCtD
Glipizide—Dyspnoea—Doxorubicin—testicular cancer	0.000535	0.000824	CcSEcCtD
Glipizide—Feeling abnormal—Epirubicin—testicular cancer	0.000534	0.000823	CcSEcCtD
Glipizide—Somnolence—Doxorubicin—testicular cancer	0.000533	0.000821	CcSEcCtD
Glipizide—Gastrointestinal pain—Epirubicin—testicular cancer	0.00053	0.000817	CcSEcCtD
Glipizide—Dyspepsia—Doxorubicin—testicular cancer	0.000528	0.000813	CcSEcCtD
Glipizide—Decreased appetite—Doxorubicin—testicular cancer	0.000521	0.000803	CcSEcCtD
Glipizide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000518	0.000798	CcSEcCtD
Glipizide—Urticaria—Epirubicin—testicular cancer	0.000515	0.000793	CcSEcCtD
Glipizide—Pain—Doxorubicin—testicular cancer	0.000513	0.00079	CcSEcCtD
Glipizide—Constipation—Doxorubicin—testicular cancer	0.000513	0.00079	CcSEcCtD
Glipizide—Abdominal pain—Epirubicin—testicular cancer	0.000512	0.000789	CcSEcCtD
Glipizide—Hypersensitivity—Methotrexate—testicular cancer	0.00051	0.000786	CcSEcCtD
Glipizide—Asthenia—Methotrexate—testicular cancer	0.000497	0.000766	CcSEcCtD
Glipizide—Feeling abnormal—Doxorubicin—testicular cancer	0.000494	0.000761	CcSEcCtD
Glipizide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00049	0.000756	CcSEcCtD
Glipizide—Pruritus—Methotrexate—testicular cancer	0.00049	0.000755	CcSEcCtD
Glipizide—Hypersensitivity—Epirubicin—testicular cancer	0.000478	0.000736	CcSEcCtD
Glipizide—Urticaria—Doxorubicin—testicular cancer	0.000476	0.000734	CcSEcCtD
Glipizide—Abdominal pain—Doxorubicin—testicular cancer	0.000474	0.00073	CcSEcCtD
Glipizide—Diarrhoea—Methotrexate—testicular cancer	0.000474	0.00073	CcSEcCtD
Glipizide—Asthenia—Epirubicin—testicular cancer	0.000465	0.000716	CcSEcCtD
Glipizide—Pruritus—Epirubicin—testicular cancer	0.000459	0.000707	CcSEcCtD
Glipizide—Dizziness—Methotrexate—testicular cancer	0.000458	0.000706	CcSEcCtD
Glipizide—Diarrhoea—Epirubicin—testicular cancer	0.000443	0.000683	CcSEcCtD
Glipizide—Hypersensitivity—Doxorubicin—testicular cancer	0.000442	0.000681	CcSEcCtD
Glipizide—Vomiting—Methotrexate—testicular cancer	0.00044	0.000678	CcSEcCtD
Glipizide—Rash—Methotrexate—testicular cancer	0.000437	0.000673	CcSEcCtD
Glipizide—Dermatitis—Methotrexate—testicular cancer	0.000436	0.000672	CcSEcCtD
Glipizide—Headache—Methotrexate—testicular cancer	0.000434	0.000669	CcSEcCtD
Glipizide—Asthenia—Doxorubicin—testicular cancer	0.00043	0.000663	CcSEcCtD
Glipizide—Dizziness—Epirubicin—testicular cancer	0.000429	0.00066	CcSEcCtD
Glipizide—Pruritus—Doxorubicin—testicular cancer	0.000424	0.000654	CcSEcCtD
Glipizide—Vomiting—Epirubicin—testicular cancer	0.000412	0.000635	CcSEcCtD
Glipizide—Nausea—Methotrexate—testicular cancer	0.000411	0.000634	CcSEcCtD
Glipizide—Diarrhoea—Doxorubicin—testicular cancer	0.00041	0.000632	CcSEcCtD
Glipizide—Rash—Epirubicin—testicular cancer	0.000409	0.00063	CcSEcCtD
Glipizide—Dermatitis—Epirubicin—testicular cancer	0.000408	0.000629	CcSEcCtD
Glipizide—Headache—Epirubicin—testicular cancer	0.000406	0.000626	CcSEcCtD
Glipizide—Dizziness—Doxorubicin—testicular cancer	0.000397	0.000611	CcSEcCtD
Glipizide—Nausea—Epirubicin—testicular cancer	0.000385	0.000593	CcSEcCtD
Glipizide—Vomiting—Doxorubicin—testicular cancer	0.000381	0.000588	CcSEcCtD
Glipizide—Rash—Doxorubicin—testicular cancer	0.000378	0.000583	CcSEcCtD
Glipizide—Dermatitis—Doxorubicin—testicular cancer	0.000378	0.000582	CcSEcCtD
Glipizide—Headache—Doxorubicin—testicular cancer	0.000376	0.000579	CcSEcCtD
Glipizide—Nausea—Doxorubicin—testicular cancer	0.000356	0.000549	CcSEcCtD
